NCT04255615 Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes
| NCT ID | NCT04255615 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Infertility |
| Study Type | INTERVENTIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2020-02-12 |
| Primary Completion | 2029-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 4,000 participants in total. It began in 2020-02-12 with a primary completion date of 2029-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The use of machine learning techniques using an artificial intelligence tool is proposed to analyze clinical data to predict best possible IVF/ART outcomes. This tool has been utilized to accurately predict embryo quality here at Cornell. Utilizing this tool to assess objective clinical findings and predict outcomes of assisted reproductive techniques is sought, with the ultimate goal of an automated tool to reduce implicit physician bias. Within this goal, using this tool to objectively and accurately assess baseline ovarian reserve at the start of an ART cycle is proposed, using 3D sonography to image the ovary and artificial intelligence tool to objectively identify baseline antral follicle counts.
Eligibility Criteria
Inclusion Criteria: * All patients undergoing ovarian stimulation (including OI and IVF cycles) * Treatment for fresh embryo transfer and cryopreservation of oocytes or embryos upfront * Healthy male partners of the female subjects who agree to be part of the study. Exclusion Criteria: * None
Contact & Investigator
Nikica Zaninovic, PHD
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT04255615 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04255615 currently recruiting?
Yes, NCT04255615 is actively recruiting participants. Contact the research team at nizanin@med.cornell.edu for enrollment information.
Where is the NCT04255615 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT04255615 clinical trial?
NCT04255615 is sponsored by Weill Medical College of Cornell University. The principal investigator is Nikica Zaninovic, PHD at Weill Medical College of Cornell University. The trial plans to enroll 4,000 participants.